Johnson & Johnson (NYSE:JNJ) this week reported results from a real-world evidence study of its CareAdvantage program, touting improved tray set up time and reduced surgical tray numbers with an estimated $262,000 saved annually.
The data was presented at the Academic Orthopaedic Consortium’s annual meeting yesterday, the company said.
“An important priority for UCSF as an academic institution is optimizing our OR processes and delivering better care to our patients. The study results provide insights about how we can achieve our goals by reducing the variation in clinical processes, lowering our inventory costs and physical footprint, improving our clinical staff’s productivity, reducing environmental impact, and helping enhance quality of care,” UCSF orthopedic surgery dept. chief administrative officer Richard Capra said in a prepared statement.
The study aimed to examine improvements in surgical instrument tray set-up time, as well as several other endpoints, for total knee and hip procedures using J&J’s CareAdvantage.
Results from the trial indicated a 3 minute reduction in tray set up time for hip procedures and 6 minute reduction for knee procedures, as well as a 57% reduction in the total number of surgical instrument trays and a 29% decrease in the number of instruments used across both types of procedures. J&J also reported a 46% reduction in the average number of open trays.
Total savings was estimated to be more than $262,000 annually, Johnson & Johnson reports.
“Approaches such as the one used by JJMDC and UCSF can help hospitals and health systems make important strides in addressing perioperative management. As both academic institutions and other systems seek how to deliver efficiencies and better outcomes, improving the processes involved in performing surgical operations can be a critical area to make an impact,” Academic Orthopaedic Consortium founder Michael Gagnon said in a prepared release.
Johnson & Johnson said that results from a recent US health systems survey indicated that 64% of executives and 56% of clinicians are seeking strategies to increase perioperative efficiency.
“Perioperative efficiency is an important area of focus for health systems seeking to improve clinical processes, lower operational costs and enhance patient outcomes. Our CareAdvantage approach starts with listening and focuses on leveraging data to identify goals and create actionable plans for improvement for health systems to achieve value-based care,” J&J MDC health economics and market access VP Dr. Christina Farup said in a press release.
In August, J&J touted its CareAdvantage supply chain services, saying it helped Spectrum Health and its 12-hospital system cut weekly out-of-stock devices by nearly 50%, reduced expedited shipping fees and the number of days products are out of stock.
Early rates for DeviceTalks Boston end August 15th.
Don't miss the chance to save $100 and join top medtech innovators including leaders from Hologic, Google, Gray Matter, TransEnterix, NxStage Medical, Smith & Nephew, HeartFlow, Dynatronics, Johnson & Johnson, Allied Minds, and many more.
View Full Agenda
Register today to save. Use code LASTCALL to save an additional 10%.